1 documents found
Information × Registration Number 0302U003366, 0102U000793 , R & D reports Title Open clinical study evaluation of the efficacy and tolerability of Cephntiaxon-Darnitsa pulver p/in 0,5 and 1,0 by ZAO FF Darnitsa production in trial of pneumonia popup.stage_title Відкрите дослідження по вивченню ефективності та переносимості препарату Цефтріаксон-Дарниця, порошок д/ін по 0,5 і 1,0 виробництва ЗАТ "ФФ Дарниця" в лікуванні пневмонії Head Svintsitskij A.S., Registration Date 05-07-2002 Organization National Medical University popup.description2 It was carried out the open randomized study of the generic drug "Cephtriaxon-Darnitsa pulver for injection 0,5 and 1,0" efficacy in comparison to Rocephin by "Hoffman La Roche" in patients with pneumonia. The main group consisted of 30 pts, the control one -of 30pts. The efficacy of Cephtriaxon-Darnitsa was proved in 73% of cases comparabel to control group. No evidence of side-effects was noticed and tolerability Cephtriaxon-Darnitsa in revealed to be high. Pulver for injection Cephtriaxon-Darnitsa may beused in clinical practice.5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
Open clinical study evaluation of the efficacy and tolerability of Cephntiaxon-Darnitsa pulver p/in 0,5 and 1,0 by ZAO FF Darnitsa production in trial of pneumonia
Head: Svintsitskij A.S.. Open clinical study evaluation of the efficacy and tolerability of Cephntiaxon-Darnitsa pulver p/in 0,5 and 1,0 by ZAO FF Darnitsa production in trial of pneumonia. (popup.stage: Відкрите дослідження по вивченню ефективності та переносимості препарату Цефтріаксон-Дарниця, порошок д/ін по 0,5 і 1,0 виробництва ЗАТ "ФФ Дарниця" в лікуванні пневмонії). National Medical University. № 0302U003366
1 documents found

Updated: 2026-03-25


Роздрукувати цю сторінку